Mitochondria-Associated Endoplasmic Reticulum Membranes as Potential Therapeutic Targets in Epilepsy
Huaiyu Sun1, Xuewei Li2, Weixuan Zhao1
1Department of Neurology, The First Hospital of Jilin University, Changchun, Jilin, China.
Background:
Mitochondria-associated endoplasmic reticulum membranes (MAMs) are specialized regions in cells where the endoplasmic reticulum and mitochondria closely interact. MAMs are enriched with a variety of proteins that regulate key cellular processes. These processes include mitochondrial fission and fusion, autophagy, lipid metabolism, calcium homeostasis, and oxidative stress. Increasing evidence suggests that disruption of MAMs structure and alterations in associated protein expression patterns are closely related to the pathogenesis of epilepsy.
Methods:
This review synthesizes and analyzes current literature to outline the structural and functional roles of key MAMs proteins. It further examines experimental and clinical evidence linking MAMs dysregulation to epileptogenesis and treatment responses.
Results:
The analysis confirms that MAMs serve as a central hub coordinating cellular homeostasis. Specific alterations in MAMs structure and protein expression are consistently associated with epilepsy models. These alterations directly impact neuronal excitability, synaptic function, and cell survival pathways involved in disease progression.
Conclusion:
Addressing these structural and functional properties of MAMs may provide valuable insights for developing novel therapeutic strategies for epilepsy.
More Related Videos
09:34Study of Endoplasmic Reticulum and Mitochondria Interactions by In Situ Proximity Ligation Assay in Fixed Cells
Published on: December 10, 2016
10:32Mitochondria-associated ER Membranes MAMs and Glycosphingolipid Enriched Microdomains GEMs: Isolation from Mouse Brain
Published on: March 4, 2013
Related Concept Videos
Antiepileptic Drugs: Glutamate Antagonists
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
The Endoplasmic Reticulum
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
